About Array Skin Therapy
- First mover in a brand-new, untapped healthcare category - Category leadership opportunity - Provide life-changing care - Recurring, insurance-covered revenue model - High patient demand, low access - Expanding market - Proven, FDA approved treatment - Simple, scalable operations - Excellent patient retention - Pregnancy-friendly, safe for all ages
Array Skin Therapy is pioneering a new category in healthcare: specialty narrowband UVB clinics — convenient, outpatient centers delivering the gold-standard, drug-free solution for chronic skin conditions like psoriasis, eczema, vitiligo, and more. Patients today are stuck navigating outdated hospital systems and overwhelmed dermatology offices just to access narrowband UVB light therapy — if they can find it at all. Long waits, limited appointments, and parking hassles make the experience frustrating and hard to stick with. Our vision is simple: anyone who needs narrowband UVB light therapy should have convenient access to it — through clinics that deliver a great patient experience. We're creating a new standard of care: specialty narrowband UVB clinics that get patients in, treated, and back to their lives quickly. For franchise owners, this is a rare ground-floor opportunity to lead the growth of a category the rest of the industry hasn't even discovered yet. With almost no competition, strong recurring revenue through insurance-covered treatments, and rising demand for drug-free solutions, Array Skin Therapy is positioned to become the dominant leader in Specialty Narrowband UVB Clinics. This isn’t just a franchise — it’s a healthcare movement.
Ideal candidate
FDD facts
| Initial franchise fee | $55K |
| Royalty | $2,000 per month Year 1; $3,000 per month Year 2; $3,500 per month Year 3; $4,500 per month Year 4; $5,000 per month Year 5+ |
| Total investment | $175K - $399K |
| Liquid capital required | $150K |
| Net worth requirement | $500K |
| Year founded | 2011 |
| Year began franchising | 2022 |
| Owner-operator required (Year 1) | No |
